Research library
Grade CRegistered trial2025n=224

Gender/Sex & CUD Remission

Medical University of South Carolina

ClinicalTrials.gov, 2025-10-27

Plain English summary

This clinical trial investigated an eight-week cognitive-behavioral therapy intervention aimed at helping adults reduce or quit cannabis use. Researchers monitored participants' cannabis use patterns and salivary progesterone levels to explore the role of sex and gender in cannabis use disorder remission.

Outcome

Study outcomes are pending as no results were reported in the trial registry summary.

Abstract

Conditions: Cannabis Use Disorder, Mild, Cannabis Use Disorder, Moderate, Cannabis Use Disorder, Severe Status: COMPLETED Enrolment: 224 Adults (ages 18+) who would like to reduce their cannabis use (N=224) will be enrolled in an 8-week treatment program. All participants will receive counseling (1 goals session with a therapist followed by 7 weekly computerized cognitive-behavioral therapy sessions). Detailed cannabis assessments (biological and self-report) will be conducted throughout treatment and at 1-, 2-, and 3-months post-treatment completion. Daily electronic diaries will be administered via text message to record detailed logs of cannabis use quantity and frequency. Salivary samples will be collected (and video observed) daily throughout treatment to analyze for progesterone.

Conditions

cannabis use disorder

Body systems

Summary generated automatically from the published abstract for educational purposes. Not medical advice. Always consult the original source and a qualified clinician.